Fig. 2From: A study of glycemic perturbations following two doses of COVID-19 vaccination for patients with diabetes: the impacts of vaccine type and anti-diabetes drugsForest plot of the effects of each COVID-19 vaccine and each anti-diabetic drug on the elevation of HbA1c among participants, determined using logistic regression modelingFigure legend: Moderna vaccines independently predict the elevation of HbA1c (OR 1.737, 95% CI 1.12–2.693, P = 0.014), and SGLT2i was negatively associated with it (OR 0.535, 95% CI 0.309–0.927, P = 0.026)Back to article page